A novel sporadic Burkitt lymphoma cell line (BLUE-1) with a unique 
t(6;20)(q15;q11.2) rearrangement

Burmeister, Thomas; MacLeod, Roderick A. F.; Reinhardt, Richard; Mansmann, Veit; Loddenkemper, Christoph; Marinets, Olga; Drexler, Hans G.; Thiel, Eckhard; Blau, Igor Wolfgang

doi:10.1016/j.leukres.2006.03.026

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

A novel sporadic Burkitt lymphoma cell line (BLUE-1) with a unique t(6;20)(q15;q11.2) rearrangement

MPS-Authors

/persons/resource/persons50488

Reinhardt, Richard
High Throughput Technologies, Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Burmeister, T., MacLeod, R. A. F., Reinhardt, R., Mansmann, V., Loddenkemper, C., Marinets, O., et al. (2006). A novel sporadic Burkitt lymphoma cell line (BLUE-1) with a unique t(6;20)(q15;q11.2) rearrangement. Leukemia Research: Interdisciplinary International, 30(11), 1417-1423. doi:10.1016/j.leukres.2006.03.026.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-8347-4

Abstract

We report the establishment and characterization, including HLA-typing, immunophenotypic and molecular cytogenetic analysis, of a novel EBV-negative cell line (BLUE-1) derived from adult relapsed sporadic Burkitt lymphoma. BLUE-1 carries the pathognomonic t(8;14)(q24;q32) effecting MYC/IgHJ fusion and a novel t(6;20)(q15;q11.2) originally present in the patient, analysis of which may facilitate identification of gene target(s) of recurrent 6q rearrangements in B-cell neoplasia. Our findings are discussed in light of the current understanding of endemic and sporadic Burkitt lymphoma. BLUE-1 grows well in culture and should be a useful lymphoma research tool.